NAYA Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch NAYA and buy or sell other stocks, ETFs, and their options commission-free!

About NAYA

INVO BioScience, Inc. is a fertility company. It focuses on the creation of treatment options for patients diagnosed with infertility. 

CEO
Steven M. Shum
CEOSteven M. Shum
Employees
37
Employees37
Headquarters
Sarasota, Florida
HeadquartersSarasota, Florida
Founded
2007
Founded2007
Employees
37
Employees37

NAYA Key Statistics

Market cap
1.52M
Market cap1.52M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
277.98K
Average volume277.98K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$76.80
52 Week high$76.80
52 Week low
$0.7101
52 Week low$0.7101

Stock Snapshot

The current NAYA Biosciences(NAYA) stock price is $2.25, with a market capitalization of 1.52M.

On 2026-03-17, NAYA Biosciences(NAYA) stock opened at —, reached a high of —, and a low of —.

The NAYA Biosciences(NAYA)'s current trading volume is 0, compared to an average daily volume of 277.98K.

In the last year, NAYA Biosciences(NAYA) shares hit a 52-week high of $76.80 and a 52-week low of $0.71.

In the last year, NAYA Biosciences(NAYA) shares hit a 52-week high of $76.80 and a 52-week low of $0.71.

People also own

Based on the portfolios of people who own NAYA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.